Literature DB >> 12925742

Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity.

Makoto Ishii1, Hong Fei, Jeffrey M Friedman.   

Abstract

Gold-thioglucose (GTG) induces lesions in the ventromedial nucleus of the hypothalamus, resulting in hyperphagia and obesity. To identify genes involved in the hypothalamic regulation of energy homeostasis, we used a screen for genes that are dysregulated in GTG-induced obese mice. We found that GPR7, the endogenous G protein-coupled receptor for the recently identified ligands neuropeptide B and neuropeptide W, was down-regulated in hypothalamus after GTG treatment. Here we show that male GPR7-/- mice develop an adult-onset obese phenotype that progressively worsens with age and was greatly exacerbated when animals are fed a high-fat diet. GPR7-/- male mice were hyperphagic and had decreased energy expenditure and locomotor activity. Plasma levels of glucose, leptin, and insulin were also elevated in these mice. GPR7-/- male mice had decreased hypothalamic neuropeptide Y RNA levels and increased proopiomelanocortin RNA levels, a set of effects opposite to those evident in ob/ob mice. Furthermore, ob/ob GPR7-/- and Ay/a GPR7-/- double mutant male mice had an increased body weight compared with normal ob/ob or Ay/a male mice, suggesting that the obesity of GPR7-/- mice is independent of leptin and melanocortin signaling. Female mice did not show any significant weight increase or associated metabolic defects. These data suggest a potential role for GPR7 and its endogenous ligands, neuropeptide B and neuropeptide W, in regulating energy homeostasis independent of leptin and melanocortin signaling in a sexually dimorphic manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925742      PMCID: PMC193597          DOI: 10.1073/pnas.1334189100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  From lesions to leptin: hypothalamic control of food intake and body weight.

Authors:  J K Elmquist; C F Elias; C B Saper
Journal:  Neuron       Date:  1999-02       Impact factor: 17.173

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

3.  Identification of a neuropeptide modified with bromine as an endogenous ligand for GPR7.

Authors:  Ryo Fujii; Hiromi Yoshida; Shoji Fukusumi; Yugo Habata; Masaki Hosoya; Yuji Kawamata; Takahiko Yano; Shuji Hinuma; Chieko Kitada; Taiji Asami; Masaaki Mori; Yukio Fujisawa; Masahiko Fujino
Journal:  J Biol Chem       Date:  2002-07-12       Impact factor: 5.157

4.  Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.

Authors:  J C Erickson; G Hollopeter; R D Palmiter
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

5.  Identification of natural ligands for the orphan G protein-coupled receptors GPR7 and GPR8.

Authors:  Stéphane Brezillon; Vincent Lannoy; Jean-Denis Franssen; Emmanuel Le Poul; Vincent Dupriez; Jean Lucchetti; Michel Detheux; Marc Parmentier
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

6.  Two related G protein-coupled receptors: the distribution of GPR7 in rat brain and the absence of GPR8 in rodents.

Authors:  D K Lee; T Nguyen; C A Porter; R Cheng; S R George; B F O'Dowd
Journal:  Brain Res Mol Brain Res       Date:  1999-07-23

7.  Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8.

Authors:  Hirokazu Tanaka; Tetsuo Yoshida; Norimasa Miyamoto; Toshiyuki Motoike; Hiroshi Kurosu; Kenji Shibata; Akihiro Yamanaka; S Clay Williams; James A Richardson; Natsuko Tsujino; Mary G Garry; Michael R Lerner; David S King; Brian F O'Dowd; Takeshi Sakurai; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

8.  Selective deletion of leptin receptor in neurons leads to obesity.

Authors:  P Cohen; C Zhao; X Cai; J M Montez; S C Rohani; P Feinstein; P Mombaerts; J M Friedman
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

9.  Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity.

Authors:  H Ohki-Hamazaki; K Watase; K Yamamoto; H Ogura; M Yamano; K Yamada; H Maeno; J Imaki; S Kikuyama; E Wada; K Wada
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

10.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

View more
  28 in total

1.  Compromise of endogenous neuropeptide W production abrogates the dipsogenic and pressor effects of angiotensin II in adult male rats.

Authors:  A T Pate; G L C Yosten; W K Samson
Journal:  J Neuroendocrinol       Date:  2013-12       Impact factor: 3.627

2.  Neuropeptide B induces slow wave sleep in mice.

Authors:  Noriko Hirashima; Tomomi Tsunematsu; Kanako Ichiki; Hirokazu Tanaka; Thomas S Kilduff; Akihiro Yamanaka
Journal:  Sleep       Date:  2011-01-01       Impact factor: 5.849

Review 3.  Peripheral neural targets in obesity.

Authors:  Amanda J Page; Erin Symonds; Madusha Peiris; L Ashley Blackshaw; Richard L Young
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

4.  Metabolic master regulators: sharing information among multiple systems.

Authors:  Barbara E Corkey; Orian Shirihai
Journal:  Trends Endocrinol Metab       Date:  2012-08-30       Impact factor: 12.015

Review 5.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

6.  Medical sequencing at the extremes of human body mass.

Authors:  Nadav Ahituv; Nihan Kavaslar; Wendy Schackwitz; Anna Ustaszewska; Joel Martin; Sybil Hebert; Heather Doelle; Baran Ersoy; Gregory Kryukov; Steffen Schmidt; Nir Yosef; Eytan Ruppin; Roded Sharan; Christian Vaisse; Shamil Sunyaev; Robert Dent; Jonathan Cohen; Ruth McPherson; Len A Pennacchio
Journal:  Am J Hum Genet       Date:  2007-03-05       Impact factor: 11.025

7.  Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7).

Authors:  Mariangela Urbano; Miguel Guerrero; Jian Zhao; Subash Velaparthi; S Adrian Saldanha; Peter Chase; Zhiwei Wang; Olivier Civelli; Peter Hodder; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2012-10-02       Impact factor: 2.823

8.  Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons.

Authors:  Makoto Ishii; Gang Wang; Gianfranco Racchumi; Jonathan P Dyke; Costantino Iadecola
Journal:  J Neurosci       Date:  2014-07-02       Impact factor: 6.167

9.  SAR analysis of novel non-peptidic NPBWR1 (GPR7) antagonists.

Authors:  Miguel Guerrero; Mariangela Urbano; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

10.  Mesolimbic neuropeptide W coordinates stress responses under novel environments.

Authors:  Toshiyuki Motoike; Jeffrey M Long; Hirokazu Tanaka; Christopher M Sinton; Amber Skach; S Clay Williams; Robert E Hammer; Takeshi Sakurai; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.